ConductScience.org, home

Paper39512697

Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.

Qian H and 7 others. Int J Med Sci, 2024. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155. Papers, record 39512697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39512697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decoding the Promise and Challenges of miRNA-Based Cancer Therapies: An Essential Update on miR-21, miR-34, and miR-155.
PubMed
Journal
Int J Med Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
9.06, provisional
iCite
Revised in PubMed
2024-11-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qian HHongbo
2Maghsoudloo MMazaher
3Kaboli PJParham Jabbarzadeh
4Babaeizad AAli
5Cui YYulan
6Fu JJunjiang
7Wang QQingjing
8Imani SSaber

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MicroRNAsMajor topic
NeoplasmsMajor topic
Humans
Gene Expression Regulation, Neoplastic
Precision Medicine

References118

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136815255The expression of Rab5 and its effect on invasion, migration and exosome secretion in triple negative breast cancer.Korean J Physiol Pharmacol2023https://conductscience.org/library/papers/36815255PubMed
236765409The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies.Cancer Cell Int2023https://conductscience.org/library/papers/36765409PubMed
332238921Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours.Br J Cancer2020https://conductscience.org/library/papers/32238921PubMed
423143100Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing.Nucleic Acids Res2013https://conductscience.org/library/papers/23143100PubMed
526692956MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.Am J Transl Res2015https://conductscience.org/library/papers/26692956PubMed
625977294DIANA-miRPath v3.0: deciphering microRNA function with experimental support.Nucleic Acids Res2015https://conductscience.org/library/papers/25977294PubMed
737860265Methods of miRNA delivery and possibilities of their application in neuro-oncology.Noncoding RNA Res2023https://conductscience.org/library/papers/37860265PubMed
834072348MicroRNA Therapeutics in Cancer: Current Advances and Challenges.Cancers (Basel)2021https://conductscience.org/library/papers/34072348PubMed
930405848MicroRNA-34 family in breast cancer: from research to therapeutic potential.J Cancer2018https://conductscience.org/library/papers/30405848PubMed
1038213224Correlation of miR-155-5p, KRAS, and CREB Expression in Patients with Acute Myeloid Leukemia.Clin Lab2024https://conductscience.org/library/papers/38213224PubMed
1138584226Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer.Int J Colorectal Dis2024https://conductscience.org/library/papers/38584226PubMed
1235064305MiR-21 participates in LPS-induced myocardial injury by targeting Bcl-2 and CDK6.Inflamm Res2022https://conductscience.org/library/papers/35064305PubMed
1328121346The diagnostic and prognostic values of microRNA-21 in patients with gastric cancer: a meta-analysis.Eur Rev Med Pharmacol Sci2017https://conductscience.org/library/papers/28121346PubMed
1419074548MicroRNA-regulated pathways associated with endometriosis.Mol Endocrinol2009https://conductscience.org/library/papers/19074548PubMed
1529282605miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.Cancer Metastasis Rev2018https://conductscience.org/library/papers/29282605PubMed
1638608633Evaluation of miR-155 silencing using a molecular beacon in human lung adenocarcinoma cell line.Talanta2024https://conductscience.org/library/papers/38608633PubMed
1739128096LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p.Turk J Gastroenterol2024https://conductscience.org/library/papers/39128096PubMed
1826852921Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile.Sci Rep2016https://conductscience.org/library/papers/26852921PubMed
1939068557Biomarkers for Oral Squamous Cell Carcinoma (miR-24, miR-200, and miR-34): Screening and Detection MicroRNA.Asian Pac J Cancer Prev2024https://conductscience.org/library/papers/39068557PubMed
2037210578Curcumin activates a ROS/KEAP1/NRF2/miR-34a/b/c cascade to suppress colorectal cancer metastasis.Cell Death Differ2023https://conductscience.org/library/papers/37210578PubMed

See all 118 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42978749A systematic review on the possible role of microRNA-155 in cancer treatment.Front Pharmacol2026https://conductscience.org/library/papers/42978749PubMed
42938883
Evaluation of the Diagnostic and Prognostic Potential, and Correlation with the Tumor Immune Microenvironment of a Six-miRNA Signature Associated with Platinum Sensitivity in Patients with Early-Stage Non-Small-Cell Lung Cancer.
Cancers (Basel)2026https://conductscience.org/library/papers/42938883PubMed
42850359The potential role of miR-34a and miR-34c in the regulation of pediatric high-grade glioma 4 aggressiveness.Pediatr Res2026https://conductscience.org/library/papers/42850359PubMed
42728899Expression of EBNA1 and miR-155 in Papillary Thyroid Carcinoma: A Case-Control Study in Iraqi Patients.F1000Res2025https://conductscience.org/library/papers/42728899PubMed
42699688Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential.Int J Nanomedicine2026https://conductscience.org/library/papers/42699688PubMed
42694631Non-coding RNAs in cancer: multi-omics insights, liquid biopsy advances, drug resistance mechanisms, and the road to clinical translation.Front Oncol2026https://conductscience.org/library/papers/42694631PubMed
42653348Circulating and Tissue MicroRNA Profiles Associated with Pathological Complete Response in HER2+ Breast Cancer: A Systematic Review.Int J Mol Sci2026https://conductscience.org/library/papers/42653348PubMed
42627073Unlocking the potential of microRNA as predictive biomarkers for efficacy and adverse events in immune checkpoint inhibitor therapy (Review).Mol Med Rep2026https://conductscience.org/library/papers/42627073PubMed
42609748miR-1246 as a Diagnostic, Prognostic, and Therapeutic Biomarker in Breast Cancer: A Narrative Review With Pharmacoeconomic Perspectives.Health Sci Rep2026https://conductscience.org/library/papers/42609748PubMed
42474758Acidic nuclear phosphoprotein 32A (ANP32A): structure, function, and its role in disease pathogenesis.Mol Biol Rep2026https://conductscience.org/library/papers/42474758PubMed
42246188Dual targeting of mitochondrial metabolism and Rho GTPase signaling to suppress cancer metastasis (Review).Oncol Rep2026https://conductscience.org/library/papers/42246188PubMed
42142294Functional dynamics of lncRNAs and miRNAs in cancer metabolism and neuroinflammation.Mol Biol Rep2026https://conductscience.org/library/papers/42142294PubMed
42074564Non-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications.Genes (Basel)2026https://conductscience.org/library/papers/42074564PubMed
42065054Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma.Oncol Res2026https://conductscience.org/library/papers/42065054PubMed
42064118Assessment of miR-760 expression as a potential diagnostic biomarker in oral squamous cell carcinoma: A RT-PCR study.J Oral Maxillofac Pathol2026https://conductscience.org/library/papers/42064118PubMed
42014656The role of hydroxyurea in modulating miRNA expression in sickle cell disease: molecular mechanisms and therapeutic implications.Ann Hematol2026https://conductscience.org/library/papers/42014656PubMed
41901058The Impact of Diet on Long-Term Oncological Outcomes: Investigating Nutritional Mechanisms in Cancer Prevention Management and Prognosis.Nutrients2026https://conductscience.org/library/papers/41901058PubMed
41900919MicroRNAs in Heart Failure Pathogenesis and Progression: Mechanistic Control, Biomarker Potential, and Translational Perspectives.Life (Basel)2026https://conductscience.org/library/papers/41900919PubMed
41751166Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts.Biomedicines2026https://conductscience.org/library/papers/41751166PubMed
41703602Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression.Mol Cancer2026https://conductscience.org/library/papers/41703602PubMed

See all 42 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
MIR155406947PubTator's text mininghttps://conductscience.org/library/genes/406947NCBI Gene
MIR21406991PubTator's text mininghttps://conductscience.org/library/genes/406991NCBI Gene
MIR34A407040PubTator's text mininghttps://conductscience.org/library/genes/407040NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39512697

GET https://conductscience.org/api/papers/v1/39512697/references?page=2